-
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例:华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势,细胞生物临床研究不断深化,伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成,生态圈的完善将在很大限度上推动产业快速发展。数据显示,中国细胞治疗企业融资金额不断增加,从2014年的0.2亿元增长至2019年的28.9亿元。其中,2018年中国细胞治疗企业融资额同比增长706.8%,呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇,同时也有挑战并存。后续产业的发展,将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局,企业也应积极开展生态合作以及更为密切关注市场需求动向,将疗法和新一代医疗创新技术深度融合,实现市场产品多元化与差异化,并推出独特性的精准治疗,从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value. -
艾媒报告 |2019中国按摩椅产业及共享按摩椅市场分析报告
本报告研究涉及企业/品牌/案例:京东,傲胜,荣泰健康,奥佳华,V3 group,云享云,小摩兽,码上按摩,恒林椅业,INGREM英格瑞玛,头等舱,爽蛙,尚铭电器,东方神,荣康,奥佳华,荣泰健康,豪中豪,乐金健康,康忆安,永禾康,本博,乐尔康,南极人,佳仁,茗振,QTQ,志高,乐摩吧,摩摩哒,爽客,码客街,头等舱互联奇拉,久工实业
中国老年人数量增长、亚健康人群超75.0%,具有养生需求的人群利好按摩椅市场的发展。2018年,中国按摩椅相关企业获投资金额2.6亿元,平均每笔按摩椅投资额超过5000万元。具体到两大电商销售渠道,按摩椅在天猫商城的月销售千笔以上的单品均价为3158.9元,京东商城热销前十的单品均价为6529.8元。在按摩市场细分企业中,2018荣泰健康、奥佳华第一大品类均为按摩椅,其营收占比分别为83.0%、42.2%。在按摩概念的广泛渗透下,共享按摩椅开始出现,目前主要应用场景在电影院、景区、地铁站、写字楼等。
The number of elderly people in China has increased, and the number of sub-healthy people has exceeded 75.0%. People who have health needs are in favor of the development of massage chair market. In 2018, China's massage chair-related enterprises received an investment of 260 million yuan, with an average investment of more than 50 million yuan per massage chair. Specifically to the two major e-commerce sales channels, the average price of massage chairs in Tianmao Mall is 3158.9 yuan per month, while the average price of the top ten items in Jingdong Mall is 6529.8 yuan. In the massage market segment enterprises, Rongtai Health and Ogawa's first major category in 2018 are massage chairs, whose revenue accounts for 83.0% and 42.2% respectively. Under the extensive penetration of massage concept, the sharing massage chair began to appear. At present, the main application scenarios are in cinemas, scenic spots, subway stations, office buildings, etc. -
艾媒报告|2019-2021中国口腔医院产业大数据及趋势分析报告
本报告研究涉及企业/品牌/案例:华西口腔医院,北京大学口腔医院,四川大学华西口腔医院,四川大学华西口腔医院,通策医疗,拜博口腔,瑞尔齿科,美维口腔,牙博士口腔,马泷齿科,佳美口腔,维尔口腔,美奥口腔,同步齿科,德伦口腔,爱牙,牙医管家,e看牙,牙e家,优益齿,共享牙医,牙医帮
截至2017年末,中国城市共有专业口腔医院535家,农村154家。艾媒咨询分析师认为,从专科医院领域的规模来看,在旺盛的医疗需求下,中国口腔市场还有很大的发展空间,特别是美颜经济兴起会进一步带动牙齿美白、矫正等业务发展。
从产业结构看,中国口腔行业主要包括牙种植、正畸、儿科、综合等项目,艾媒咨询分析师认为,目前中国口腔医疗正处于发展上升阶段,品牌开始获得一定认可,但发展主要集中在中低端市场,后续应当进一步向高端市场发力。从机构性质看,中国口腔医疗机构大致可分为综合性医院口腔科、公立专科口腔医院、连锁民营口腔医院及诊所和个体诊所四类。iiMedia Research(艾媒咨询)监测发现,首都医科大学附属口腔北京医院、泰康拜博等机构的排名靠前,受到更高认可度。
From the industrial structure, China's oral industry mainly includes dental implantation, orthodontics, pediatrics, comprehensive and other projects, Ai media consulting analysts believe that China's oral medicine is currently in the stage of development and rise, the brand began to get a certain recognition, but the development is mainly concentrated in the low-end market, the follow-up should further to the high-end market. From the institutional nature, China's oral medical institutions can be broadly divided into general hospital oral medicine, public specialized oral hospitals, chain private oral hospitals and clinics and individual clinics four categories. iiMedia Research monitoring found that the Capital Medical University affiliated oral Beijing Hospital, Taikang Baibo and other institutions ranked high, received a higher degree of recognition. -
艾媒报告|2019-2022中国医疗器械市场大数据及标杆企业运行监测报告
本报告研究涉及企业/品牌/案例:安健科技,万东医疗,康达国际,上海联影,深圳迈瑞佳能,飞利浦,柯达,西门子,GE,安健,万东,通用电气,安科,东软丹纳赫,罗氏,利德曼,强生,科华,美康,九强,日立,迈克,东芝,中生,雅培,迪瑞,大基康明,金杏,致远,成武,长庚,康健,鑫乐,瑞琦,力因精准,积水,威高,拱东,三力,阳普医疗,BD,奥凯龙,重庆多泰,成都威力生,广州暨华,威海威高,山外山,金宝,尼普洛,百特,贝朗,费森透析,美敦力,鱼疗,理邦,尚荣医疗,英科医疗
相比于全球医疗器械市场,近三年中国医疗器械市场的结构已趋向优化但结构依然严重不平衡。早期中国医疗器械市场中,中低端产品占据了将近70%的比例,而高端产品仅占30%左右的比例,而国际医疗器械市场的结构为高端产品占55%,低端产品占45%。如新华医疗、迪安诊断、乐普医疗、鱼跃医疗等积极开拓高端市场及寻求出海发展。艾媒咨询分析师认为,受人工智能、物联网、5G等技术的影响,高端化、智能化和家庭化是中国医疗器械产业发展最为显著的三大趋势。特别是医疗大数据、高端医疗影像设备、家用医疗器械、智能便携式医疗设备等领域将会备受关注。
Compared with the global medical device market, the structure of China's medical device market has been optimized in the past three years, but the structure is still seriously unbalanced. In the early Chinese medical device market, low-end products accounted for nearly 70% of the proportion, while high-end products accounted for only about 30%, while the international medical device market accounted for 55% of high-end products and 45% of low-end products. Such as Xinhua Medical, Dean Diagnostics, Lepu Medical, Yuyue Medical, etc. actively explore the high-end market and seek to develop. iiMedia Research analysts believe that high-end, intelligent and family-oriented are the three most significant trends in the development of China's medical device industry due to the impact of artificial intelligence, Internet of Things, 5G and other technologies. In particular, medical big data, high-end medical imaging equipment, home medical equipment, smart portable medical equipment and other fields will be of great concern. -
艾媒报告 |2019中国基因测序产业研究和商业应用分析报告
本报告研究涉及企业/品牌/案例:Thermo Fisher(美),Illuminate(美),(瑞士),Stem cells(加),R&D(瑞士),华大基因,贝瑞基因,金城检验,美吉生物,恒创基因,基研生物,谱元科技,景杰生物,燃石生物,基迪奥生物,谷和信息,圣庭生物,天昊生物,诺禾致源,百迈克生物,思博奥科,赛莱拉,赛贝、北昊干细胞,达安基因,燃石医学、泛生子基因、世和基因,臻和生物,鹍远基因,23魔方,瀚海基因,百奥赛图,克睿基因,药明明码,裕策生物
随着基因测序的技术推进,基因测序开始应用于生物、侦查、无创产前检测和肿瘤治疗等场景中。技术的市场化应用吸引了全球资本方关注,iiMedia Research(艾媒咨询)数据显示,2018年全球医疗健康领域资本市场中,生物技术领域获得309件投资案共138亿元美元,领跑所有细分领域。中国生物技术科研研发实力厚积薄发,特别是科创板推动了基因测序市场的进一步升温,越来越多的生物创业公司在创业初期已获得高额融资。目前,中国已经基本形成了完整的上中下游产业链,但除了华大基因、贝瑞基因等少数头部企业,中国基因测序企业多数分布于产业链中下游,并且开始出现产品同质化等问题。艾媒咨询分析师认为,第二代测序技术的普及以及第三代测序技术的加紧研发将使得基因测序作为一个更加普遍的技术手段应用到不同场景之中,但目前仍然存在监管体系不够完善、道德伦理风险等问题。企业方面应当专注研究核心技术专利,通过人才储备和差异化竞争获得市场优势;行业和相关部门应当尽快完善行业规范管理体系,推动产业健康发展。
With the advancement of gene sequencing technology, gene sequencing began to be used in biological, detection, noninvasive prenatal testing and tumor treatment and other scenarios. The market-oriented application of technology has attracted global capital attention, with iiMedia Research leading all segments of the world in 309 investments in the global healthcare capital markets in 2018, with 309 investments, according to iiMedia Research. China's biotechnology research and development strength thick and thin hair, especially the science and technology board to promote the gene sequencing market further heating up, more and more bio-startup companies in the early stage of the start-up has been high financing. At present, China has basically formed a complete upstream and downstream industrial chain, but in addition to Huada gene, Berry gene and a few other head enterprises, Most of China's gene sequencing enterprises are distributed in the middle and lower reaches of the industrial chain, and began to appear product homogenization and other issues. Ai media consulting analysts believe that the popularity of second-generation sequencing technology and the third generation of sequencing technology will make gene sequencing as a more common technical means to apply to different scenarios, but there are still problems such as inadequate regulatory system, ethical risks. Enterprises should focus on researching core technology patents and gain market advantages through talent pool and differentiated competition, and industries and related departments should improve the industry standard management system as soon as possible to promote the healthy development of the industry. -
艾媒报告 |2019中国零售购物双线购新模式发展白皮书
本报告研究涉及企业/案列/品牌:屈臣氏,沃尔玛,网易考拉,阿里巴巴,京东,奥买家,银泰百货,百联集团,太平洋百货,新世界百货中国,百胜集团,新华百货,天虹百货,万达百货,返利网,万达非凡,寺库,多点新鲜,苏宁易购,腾讯,淘宝,永辉超市,家乐福,中百控股三江购物
随着全球经济的不断升温,零售行业也随之迅猛发展。2018年全球零售销售额达到27.73万亿美元,其中,中国社会消费品零售总额增至38.1万亿元,2020年有望突破40万亿元。而在各项新兴技术发展及消费者消费体验需求提升的背景下,零售行业进入新零售阶段。其中强调线上线下渠道深度融合的双线购模式成为新零售典范。iiMedia Research(艾媒咨询)数据显示,超五成消费者认可线上渠道价格低廉和购物方便优势,而线下渠道品质保障和购物体验提升则更受认可。渠道差异下,消费者期待融合全渠道优势的双线购平台出现,68.2%消费者表示未来愿意尝试使用双线购平台。线上线下购物渠道基于渠道属性各自优势呈现差异化,但二者优势又能互作补充,线上线下融合在满足消费需求方面更适应零售购物渠道发展的趋势。但消费者对于双线购模式认知仍存偏差,全渠道打通成消费者最迫切需求。
As the global economy keeps heating up, the retail industry is booming. In 2018, the amount of global retail sales reached 27.73 trillion dollars, of which the total amount of retail sales of consumer goods in China increased to 38.1 trillion yuan, and it is expected to exceed 40 trillion yuan in 2020. In the context of the development of various emerging technologies and the increasing demand for consumer experience, the retail industry has entered the stage of New Retailing. The double-channel retail shopping model, which emphasizes the deep integration of online and offline channels, has become a nonesuch of new retail shopping models. As the data of iiMedia Research showed, over 50% of consumers recognize the advantages of low price and shopping convenience for online channel, while the advantages of quality assurance and shopping experience enhancement are more recognized for offline channel. As the shopping characteristics differentiate for different channels, consumers are expecting the emergence of double-channel retail shopping platform with integrated channel advantages, and 68.2% of consumers imply that they are willing to try to shop in the double-channel retail shopping platform in the future. The online and offline shopping channels are different based on their respective advantages of channel attributes, but their advantages can complement each other accodingly. The online and offline integration is more suitable for the development of retail shopping channels in meeting consumer demand. However, consumers still have a bias in the perception of the double-channel retail shopping model, and the omni-channel interrelated has become the most urgent demand of consumers -
艾媒报告 |2019中国茶行业市场大数据及标杆商业模式研究报告
本报告研究涉及企业/品牌/案例:小罐茶,大益茶,艺福堂,小马茶业,喜茶,二奈雪の茶,益禾堂,19tea,一芳台湾水果茶,鹿角巷the Ally,一点点,一些柠檬一些茶,四云奶盖贡茶,Taning挞柠•匠心柠檬茶,答案茶,丧茶,快乐柠檬,茶の井,CoCo都可,大卡司,吴裕泰茶业,黄山王光熙松萝茶业股份公司,天府(開曼)控股有限公司,四川省峨眉山竹叶青茶业有限公司,武夷星茶业有限公司,勐海陈升茶业有限公司,咸阳泾渭茯茶有限公司,湖南华莱生物科技有限公司
2019年,中国茶叶产量产值不断上涨,出口量出口额不断增加,内销量与内销额也不断提高,茶行业未来发展前景具有巨大的潜力。中国茶行业已形成全产业链,同时形成了具有规模的线上茶叶市场,截至2019年,中国茶叶线上市场规模达到235.0亿元。中国茶叶经典品牌小罐茶,整合上游茶园资源,并重视技术革新,建立智能化工厂,形成大规模的茶园和生产加工厂,于2019年收获了4.0亿元人民币的融资资本。另外,中国茶叶后市场兴起,带动了年轻一代消费者对茶叶的消费的热情,如新式茶饮品牌喜茶,用创新的产品设计、良好的定价策略以及精准的市场定位,成功开拓出新式茶饮的市场,收获4.0亿元的融资,完成布局31个地区。
In 2019, the output value of China's tea production continued to rise, the export volume of exports continued to increase, and the volume of domestic sales and domestic sales continued to increase. The future development prospects of the tea industry have great potential. The Chinese tea industry has formed a full industrial chain, and at the same time formed a large-scale online tea market. By 2019, the Chinese tea online market reached 23.5 billion yuan. China's tea classic brand XIAO GUAN TEA, integrated upstream tea garden resources, and attached importance to technological innovation, the establishment of intelligent factories, the formation of large-scale tea gardens and production processing plants, harvested 400 million yuan of financing capital in 2019. In addition, the rise of the Chinese tea market has spurred the enthusiasm of the younger generation of consumers for tea consumption, such as the new tea HEYTEA, with innovative product design, good pricing strategy and precise market positioning, successfully developed new tea. The market for drinking, harvesting 400 million yuan of financing, completed the layout of 31 regions. -
艾媒报告 |2019年中国生物医药产业发展及舆论焦点分析报告
本报告研究涉及企业/品牌包括:Takeda、GSK、Sanofi、Celgene、Novartis、宝洁、CVC Fund VII、Shire、诺华OTC、Bioverativ、Juno Therapeutics、AveXis、Impact Biomedicines、Tesaro、Ablynx、默克OTC、Recordati控股公司FIMEI、复星医药、海正药业、康弘药业、泰合健康、齐鲁制药、复宏汉霖、信达生物、张江生物、恒瑞医药、三生国健、嘉和生物、百奥泰、深圳龙瑞、天坛生物、华兰生物、博雅生物、上海莱士、卫光生物、辽宁成大、智飞生物、康泰生物、沃森生物、利德曼、交大昂立、华润双鹤、力生制药、海欣股份、联环药业、白云山、中源协和、普洛药业
随着生物医药技术不断突破,中国生物医药产业快速发展,2018年,单抗、血液制品、疫苗等生物医药相关领域多家头部上市企业营收均超亿元,实现同比增长。iiMedia Research(艾媒咨询)监测发现,生物医药产业网络言值指数为49.7,网民评价态度偏向正面,上海网民对生物医药产业的关注度最高。未来,随着中国生物医药行业上市公司数量增多,行业与企业间竞争将更加激烈。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.
- 1
- 2
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告